Compare China Medical System Holdings Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 19.26%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 77.55
3
High Debt company with Weak Long Term Fundamental Strength
4
Flat results in Jun 25
5
With ROE of 9.50%, it has a Fair valuation with a 1.71 Price to Book Value
6
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.31%
0%
9.31%
6 Months
1.99%
0%
1.99%
1 Year
76.26%
0%
76.26%
2 Years
89.8%
0%
89.8%
3 Years
15.56%
0%
15.56%
4 Years
16.31%
0%
16.31%
5 Years
-13.05%
0%
-13.05%
China Medical System Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.25%
EBIT Growth (5y)
-8.17%
EBIT to Interest (avg)
77.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.52
Tax Ratio
23.80%
Dividend Payout Ratio
40.22%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
27.22%
ROE (avg)
19.26%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.71
EV to EBIT
14.64
EV to EBITDA
12.61
EV to Capital Employed
2.03
EV to Sales
3.08
PEG Ratio
0.91
Dividend Yield
NA
ROCE (Latest)
13.85%
ROE (Latest)
9.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Jun 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
8,098.10
8,854.70
-8.54%
Operating Profit (PBDIT) excl Other Income
2,071.10
3,203.90
-35.36%
Interest
41.90
51.10
-18.00%
Exceptional Items
-100.80
-348.30
71.06%
Consolidate Net Profit
1,748.90
2,634.80
-33.62%
Operating Profit Margin (Excl OI)
221.00%
333.20%
-11.22%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -8.54% vs -16.78% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -33.62% vs -30.84% in Dec 2023
About China Medical System Holdings Ltd. 
China Medical System Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






